Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adherence and Persistence to Tocilizumab With or Without Methotrexate in Rheumatoid Arthritis
2009-011520-53Phase 4Completed
- Sponsor
- Roche
- Start
- Mar 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of tocilizumab in rheumatoid arthritis (RA) (2 arms), sponsored by Roche. Primary endpoint: Primary adherence endpoint. Started Mar 2009; status: completed.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2009-011520-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011520-53.